SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer

被引:24
|
作者
Schaefer, Thorsten [1 ,2 ]
Steiner, Rebekah [2 ,3 ]
Lengerke, Claudia [1 ,2 ,4 ]
机构
[1] Univ Basel, Dept Biomed, Stem Cells & Hematopoiesis Lab, CH-4031 Basel, Switzerland
[2] Univ Hosp Basel, CH-4031 Basel, Switzerland
[3] Univ Basel, Dept Biomed, Immunol Lab, CH-4031 Basel, Switzerland
[4] Univ Hosp Tubingen, Internal Med 2, D-72076 Tubingen, Germany
关键词
SOX2; p53; PI3K; AKT signaling; stem cells; pluripotency; genome integrity; DNA maintenance; DNA damage response (DDR); transformation; cancer; DNA-DAMAGE RESPONSE; CELL SELF-RENEWAL; HEMATOPOIETIC STEM; MUTANT P53; TRANSCRIPTION FACTORS; SOMATIC-CELLS; TUMOR-SUPPRESSOR; STRESS DEFENSE; REPAIR DEFECTS; MOUSE;
D O I
10.3390/ijms21144902
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stemness and reprogramming involve transcriptional master regulators that suppress cell differentiation while promoting self-renewal. A distinguished example thereof is SOX2, a high mobility group (HMG)-box transcription factor (TF), whose subcellular localization and turnover regulation in embryonic, induced-pluripotent, and cancer stem cells (ESCs, iPSCs, and CSCs, respectively) is mediated by the PI3K/AKT/SOX2 axis, a stem cell-specific branch of the PI3K/AKT signaling pathway. Further effector functions associated with PI3K/AKT induction include cell cycle progression, cellular (mass) growth, and the suppression of apoptosis. Apoptosis, however, is a central element of DNA damage response (DDR), where it provides a default mechanism for cell clearance when DNA integrity cannot be maintained. A key player in DDR is tumor suppressor p53, which accumulates upon DNA-damage and is counter-balanced by PI3K/AKT enforced turnover. Accordingly, stemness sustaining SOX2 expression and p53-dependent DDR mechanisms show molecular-functional overlap in PI3K/AKT signaling. This constellation proves challenging for stem cells whose genomic integrity is a functional imperative for normative ontogenesis. Unresolved mutations in stem and early progenitor cells may in fact provoke transformation and cancer development. Such mechanisms are also particularly relevant for iPSCs, where genetic changes imposed through somatic cell reprogramming may promote DNA damage. The current review aims to summarize the latest advances in the understanding of PI3K/AKT/SOX2-driven stemness and its intertwined relations to p53-signaling in DDR under conditions of pluripotency, reprogramming, and transformation.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 50 条
  • [41] Coordination of tumor suppressor p53 and PI3K/PTEN-Akt-mTOR signaling pathways in glioblastoma multiforme pathogenesis
    Jamoona, Amrith
    Zohrabian, Vahe M.
    Braun, Alex
    Murali, Raj
    Jhanwar-Uniyal, Meena
    CANCER RESEARCH, 2006, 66 (08)
  • [42] Positive Effects of PI3K/Akt Signaling Inhibition on PTEN and P53 in Prevention of Acute Lymphoblastic Leukemia Tumor Cells
    Naderali, Elahe
    Valipour, Behnaz
    Khaki, Amir Afshin
    Rad, Jafar Soleymani
    Alihemmati, Alireza
    Rahmati, Mohammad
    Charoudeh, Hojjatollah Nozad
    ADVANCED PHARMACEUTICAL BULLETIN, 2019, 9 (03) : 470 - 480
  • [43] IRF4-induced upregulation of IncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling
    Wei, C-X
    Wong, H.
    Xu, F.
    Liu, Z.
    Ran, L.
    Jiang, R-D
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (23) : 8169 - 8178
  • [44] SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway
    Yang, Ning
    Hui, Lian
    Wang, Yan
    Yang, Huijun
    Jiang, Xuejun
    ONCOLOGY REPORTS, 2014, 31 (06) : 2651 - 2659
  • [45] Targeting PI3K/Akt signaling in prostate cancer therapy
    Hashemi, Mehrdad
    Taheriazam, Afshin
    Daneii, Pouria
    Hassanpour, Aria
    Kakavand, Amirabbas
    Rezaei, Shamin
    Hejazi, Elahe Sadat
    Aboutalebi, Maryam
    Gholamrezaie, Hamidreza
    Saebfar, Hamidreza
    Salimimoghadam, Shokooh
    Mirzaei, Sepideh
    Entezari, Maliheh
    Samarghandian, Saeed
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2023, 17 (03) : 423 - 443
  • [46] Targeting PI3K/Akt signaling in prostate cancer therapy
    Mehrdad Hashemi
    Afshin Taheriazam
    Pouria Daneii
    Aria Hassanpour
    Amirabbas kakavand
    Shamin Rezaei
    Elahe Sadat Hejazi
    Maryam Aboutalebi
    Hamidreza Gholamrezaie
    Hamidreza Saebfar
    Shokooh Salimimoghadam
    Sepideh Mirzaei
    Maliheh Entezari
    Saeed Samarghandian
    Journal of Cell Communication and Signaling, 2023, 17 : 423 - 443
  • [47] Reactive oxygen species and PI3K/Akt signaling in cancer
    Yeon, Jin Seo
    Sun, Lee Hye
    Kyoung, Kim Eun
    Min, Ha Jung
    Whan, Kim Young
    SunSik, Bae
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 75 : S34 - S35
  • [48] PI3K/AKT signaling pathway and cancer: an updated review
    Martini, Miriam
    De Santis, Maria Chiara
    Braccini, Laura
    Gulluni, Federico
    Hirsch, Emilio
    ANNALS OF MEDICINE, 2014, 46 (06) : 372 - 383
  • [49] Special issue: PI3K/Akt signaling in human cancer
    Murugan, Avaniyapuram Kannan
    SEMINARS IN CANCER BIOLOGY, 2019, 59 : 1 - 2
  • [50] UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
    Zhang, Ping
    Guo, Huiping
    Zhao, Fang
    Jia, Ke
    Yang, Fei
    Liu, Xiaoli
    OPEN MEDICINE, 2023, 18 (01):